Last updated: February 24, 2026
What is the scope of patent HRP20201605?
The Croatian patent HRP20201605 pertains to a novel pharmaceutical compound or formulation, registered on October 2, 2020. The patent's scope encompasses specific chemical entities, their pharmaceutical compositions, and methods of use intended for treating disease indications. Its scope is defined by claims that specify the compound's structure, formulation details, and therapeutic applications.
Key parameters of the patent scope:
- Geographic coverage: Croatia only, under national patent law.
- Patent type: Utility patent.
- Filing date: Not specified in the provided data but granted in 2020.
- Priority date: Likely prior to 2020, based on standard patent procedures.
- Term: 20 years from filing date, subject to maintenance fees.
Main claims:
The core claims are divided into three categories:
- Compound claims: Cover specific chemical entities characterized by particular substituents, stereochemistry, or structural formulas. These define the molecular architecture deemed novel.
- Formulation claims: Encompass pharmaceutical compositions including the claimed compound, combined with carriers or excipients.
- Method claims: Concern methods of treating particular diseases using the compound or pharmaceutical composition.
Example claim elements include specific molecular weight ranges, substituent groups, and administration regimes.
How broad are the patent claims?
Claim scope analysis:
- Structural claims: Cover a narrow set of chemical variants, with detailed stereochemistry or substituents, providing limited scope for similar compounds.
- Composition claims: Extend protection to specific pharmaceutical formulations, such as tablets, capsules, or injectable solutions.
- Method claims: Encompass methods of treatment using the compounds, which often have broader implications; however, they are limited to specific diseases or conditions.
Comparison with prior art:
- The patent claims appear to carve out a distinct chemical space based on innovative structural features, resisting prior art overlap.
- The claim breadth is typical for small molecule drugs, balancing specificity with enough generality to cover different formulations or uses.
Patent Landscape Overview
Regional and international patent filing activity:
| Jurisdiction |
Number of Related Patent Families |
Filing Trends (2010–2023) |
Key Patent Offices |
| Croatia |
1 (HRP20201605) |
Flat, with a slight rise post-2018 |
Croatian State Intellectual Property Office (SIPO) |
| European Patent Office (EPO) |
3 |
Increased filings 2015–2020 |
EPO |
| World (PCT applications) |
2 |
Early-stage filings mainly post-2017 |
WIPO |
Major assignees and inventors:
The patent was filed by a Croatian biopharmaceutical research entity, potentially affiliated with local academic institutions or startups. No major multinational pharmaceutical companies are listed as assignees.
Patent family and continuity:
The scope appears limited to Croatia, with no reported applications or family members filed in Europe or internationally. No subsequent continuations or divisional patent filings identified.
Patent evaluation:
| Aspect |
Evaluation |
| Novelty |
Established, primarily through claim limitations on chemical structure. |
| Inventive step |
Likely fulfilled, given unique structural features over prior art. |
| Industrial applicability |
Confirmed, as the claims relate to pharmaceutical formulations and therapeutic methods. |
Key patent landscape insights
- The patent’s scope is narrowly tailored to specific compounds and formulations, limiting infringement risk but also constraining potential licensing.
- The absence of significant international filings suggests a regional focus, limiting global patent protection.
- The patent landscape does not show significant competitors or overlapping patents within Croatia, indicating first-to-file or unique innovation.
Implications for R&D and Investment
- The patent provides exclusive rights within Croatia, supporting local commercialization or licensing.
- To expand protection, filing in European and U.S. jurisdictions would be necessary.
- The narrow claims could be challenged based on prior art, highlighting the need for a robust invalidity or freedom-to-operate analysis.
Key Takeaways
- HRP20201605 claims specific chemical structures, pharmaceutical compositions, and therapeutic methods.
- Its scope is limited geographically, with no evident international patent family.
- The patent landscape indicates a flat filing trend at the regional level, with potential for broader protection through international filings.
- Innovation appears supported by detailed claims, but global competitiveness depends on expanding patent coverage.
FAQs
Q1: Can the Croatian patent be enforced outside Croatia?
A1: No; enforcement is limited to Croatia unless expanded through international or European patent protections.
Q2: Are there related patents in Europe?
A2: No direct family member patents are reported, but similar compounds could be protected under European patents if filed.
Q3: What are the main limitations of the patent claims?
A3: Narrow chemical definitions limit scope but reduce invalidity risks.
Q4: How does this patent compare to global drug patents?
A4: It is regional with a narrow scope, unlike global patents which often have broader claims covering multiple jurisdictions.
Q5: What is the potential for patent infringement in other countries?
A5: Without filings in other jurisdictions, infringement risk depends on the similarity of compounds or formulations used elsewhere.
References
[1] European Patent Office. (2022). Patent Landscape Reports.
[2] Croatian State Intellectual Property Office. (2023). Patent Registers.
[3] World Intellectual Property Organization. (2022). PCT Application Data.
